Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GN10415 structure
    GN10415Astilbin
    CAS: 29838-67-3
    纯度: >97.00%

    A flavonoid with diverse biological activities

  • GN10421 structure
    GN10421Kaempferol
    CAS: 520-18-3
    纯度: >99.50% / >98.00% / >97.00% / >98.50%

    Kaempferol是一种黄酮类化合物,可作为ERRα和ERRγ的反向激动剂,具有抗氧化、抗炎和抗肿瘤活性。

  • GN10429 structure
    GN10429Neochlorogenic acid
    CAS: 906-33-2
    纯度: >98.00%

    A phenolic compound with diverse biological activities

  • GN10451 structure
    GN10451Psoralen
    CAS: 66-97-7
    纯度: >99.50%

    A photoactive probe to study DNA

  • GN10453 structure
    GN10453Ginkgolide B
    CAS: 15291-77-7
    纯度: >98.00%

    Ginkgolide B是从银杏叶中提取的一种萜内酯,是血小板活化因子(PAF)的特异性拮抗剂, IC 50 为 3.6μM。

  • GN10456 structure
    GN10456L-Theanine
    CAS: 3081-61-6
    纯度: >99.50%

    A neuroprotective amino acid

  • GN10457 structure
    GN10457Oleuropein
    CAS: 32619-42-4
    纯度: >98.00%

    Oleuropein是橄榄树中的主要酚类化合物,具有强效的抗氧化和抗炎特性。

  • GN10462 structure
    GN10462Pulsatilla saponin D
    CAS: 68027-15-6
    纯度: >98.00%

    An oleanane-type saponin with anticancer activity

  • GN10463 structure
    GN10463Chelerythrine
    CAS: 34316-15-9

    Chelerythrine 是一种天然生物碱,是一种有效的选择性 Ca2+/磷脂依赖性 PKC 拮抗剂,IC50 为 0.7 μM。

  • GN10470 structure
    GN10470Eriodictyol
    CAS: 552-58-9;4049-38-1
    纯度: >99.50%

    圣草酚是一种从中药中分离出来的黄酮类化合物,具有抗氧化和抗炎活性。

  • GN10484 structure
    GN10484Amentoflavone
    CAS: 1617-53-4
    纯度: >98.00%

    A biflavonoid with diverse biological activities

  • GN10491 structure
    GN10491Mangiferin
    CAS: 4773-96-0
    纯度: >99.50%

    A xanthone glucoside with diverse biological activities

  • GN10503 structure
    GN10503Piceatannol
    CAS: 10083-24-6
    纯度: >98.00%

    Piceatannol(3,3 ',4,5 ' -反式三羟基二苯乙烯)是天然存在的白藜芦醇羟基化类似物。

  • GN10504 structure
    GN10504Echinocystic acid
    CAS: 510-30-5
    纯度: >98.00%

    A triterpene with diverse biological activities

  • GN10506 structure
    GN10506Umbelliferone
    CAS: 93-35-6
    纯度: >99.00% / >98.50% / >99.50%

    A derivative and metabolite of coumarin with diverse biological activities

  • GN10507 structure
    GN10507Baohuoside I
    CAS: 113558-15-9
    纯度: >99.50% / >98.00%

    宝活苷 I 是一种从淫羊藿中分离出来的黄酮类化合物,可作为 CXCR4 抑制剂,下调 CXCR4 表达,诱导细胞凋亡并具有抗肿瘤活性。

  • GN10520 structure
    GN10520Benzoylpaeoniflorin
    CAS: 38642-49-8
    纯度: >98.00%

    苯甲酰芍药苷是一种来自中国白芍的天然产物,可通过减少细胞凋亡来治疗冠心病。

  • GN10521 structure
    GN10521Curcumol
    CAS: 4871-97-0
    纯度: >99.00%

    A sesquiterpene alcohol with diverse biological activities

  • GN10527 structure
    GN10527Formononetin
    CAS: 485-72-3
    纯度: >99.50%

    Formononetin是一种强效的FGFR2抑制剂,其IC 50 值约为4.31μM。Formononetin能有效抑制血管生成和肿瘤生长。

  • GN10529 structure
    GN10529Demethoxycurcumin
    CAS: 22608-11-3;24939-17-1
    纯度: >99.00%

    Natural curcuminoid with roles in cancer and inflammation

  • GN10534 structure
    GN10534Asiaticoside
    CAS: 16830-15-2
    纯度: >99.50% / >98.00%

    Asiaticoside是从Centella asiatica中提取的一种五环三萜苷。

  • GN10535 structure
    GN10535Cucurbitacin B
    CAS: 6199-67-3
    纯度: >99.50% / >98.00%

    A natural triterpene

  • GN10538 structure
    GN10538Ginsenoside Rh1
    CAS: 63223-86-9
    纯度: >98.00%

    A steroid glycoside with diverse biological activities

  • GN10539 structure
    GN10539Bergenin
    CAS: 477-90-7
    纯度: >99.50%

    A glycoside with diverse biological activities